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ABSTRACT
Background The number of HIV-positive pregnant
women receiving antiretroviral drugs (ARVs) to prevent
mother-to-child transmission (MTCT) of HIV has
increased rapidly.
Objective To estimate the reduction in new child HIV
infections resulting from prevention of MTCT (PMTCT)
over the past decade. To project the potential impact of
implementing the new WHO PMTCT guidelines between
2010 and 2015 and consider the efforts required to
virtually eliminate MTCT, deﬁned as <5% transmission
of HIV from mother to child, or 90% reduction of
infections among young children by 2015.
Methods Data from 25 countries with the largest
numbers of HIV-positive pregnant women were used to
create ﬁve scenarios to evaluate different PMTCT
interventions. A demographic model, Spectrum, was
used to estimate new child HIV infections as a measure
of the impact of interventions.
Results Between 2000 and 2009 there was a 24%
reduction in the estimated annual number of new child
infections in the 25 countries, of which about one-third
occurred in 2009 alone. If these countries implement the
new WHO PMTCT recommendations between 2010 and
2015, and provide more effective ARV prophylaxis or
treatment to 90% of HIV-positive pregnant women, 1
million new child infections could be averted by 2015.
Reducing HIV incidence in reproductive age women,
eliminating the current unmet need for family planning
and limiting the duration of breastfeeding to 12 months
(with ARV prophylaxis) could avert an additional 264000
infections, resulting in a total reduction of 79% of annual
new child infections between 2009 and 2015,
approaching but still missing the goal of virtual
elimination of MTCT.
Discussion To achieve virtual elimination of new child
infections PMTCT programmes must achieve high
coverage of more effective ARV interventions and safer
infant feeding practices. In addition, a comprehensive
approach including meeting unmet family planning needs
and reducing new HIV infections among reproductive age
women will be required.
INTRODUCTION
In 2001, and again in 2006, national governments
and their development partners committed them-
selves to reducing infant and child HIV infections
through prevention of mother-to-child trans-
mission (PMTCT) by 50% by 2010.
1 2 Recently,
UNAIDS and partners have called for virtual
elimination of MTCT of HIV.
3 Virtual elimination
includes an overarching goal of reducing the
number of new child HIV infections by 90%
between 2009 and 2015 and reducing MTCT
to <5%. To prevent MTCT, the United Nations
recommends a comprehensive four-pronged
approach including (1) primary prevention of HIV
infection among women of childbearing age; (2)
preventing unintended pregnancies among women
living with HIV; (3) preventing HIV transmission
from women living with HIV to their infants and
(4) providing appropriate treatment, care and
support to mothers living with HIV and their
children and families.
4 Prongs 1, 2 and 3 are
necessary to reach the ﬁrst target of reducing new
child infections while only prong 3 will affect the
second target to lower the transmission rate.
In countries where breastfeeding is common, the
probability of transmission from mother to child
without any antiretroviral drugs (ARVs) is
approximately 20e45%: approximately 15e25%
transmission during pregnancy and 5e20% trans-
mission during breastfeeding.
5 In developed coun-
tries, where all four prongs are well implemented
and the most effective ARVs are provided to
HIV-positive pregnant women with limited
breastfeeding, the level of MTCT has decreased to
below 2%.
6e8 National measures of MTCTrates are
not available in most developing countries because
health systems cannot directly measure HIV
infections resulting from vertical transmission in
a systematic way.
In November 2009 WHO released Rapid Advice:
Use of Antiretroviral Drugs for Treating Pregnant Women
and Preventing HIV Infection in Infants and published
revised full guidelines in July 2010.
9e12 The new
guidelines emphasise the importance of treating
eligible HIV-positive pregnant women (CD4#350)
with lifelong antiretroviral therapy (ART) and
recommend two equivalent options of highly
effective prophylaxis to HIV-positive pregnant
women who do not need ART for their own health.
For the ﬁrst time ARV prophylaxis to either the
mother or child is also recommended during
breastfeeding, in settings where breastfeeding is
judged to be the safest infant feeding option.
Option A starts treatment of women with zido-
vudine at 14 weeks of gestation or as soon as
possible thereafter until delivery and the infant
receives nevirapine throughout breastfeeding and
until 1-week after exposure to breast milk has
ended. Option B starts treatment of the mother
with triple ARV prophylaxis from 14 weeks or as
soon as possible thereafter and continues the
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Supplementmaternal triple drug prophylaxis until 1-week after exposure to
breast milk has ended. In 2010 WHO also released Guidelines on
HIV and Infant Feeding, which recommend exclusive breast-
feeding for the ﬁrst 6 months of life, and continued breast-
feeding and complementary foods from months 6 to 12, when
either the mother or baby is receiving ARVs.
12
Effective prevention of MTCT requires a comprehensive
approach that combines multiple interventions. While remark-
able progress has been made in providing ARV regimens to
HIV-positive pregnant women and to some extent in providing
appropriate treatment, care and support to women living with
HIV and their children, the other two prongsdpreventing new
HIV infections among reproductive age women and avoiding
unwanted pregnancies among HIV-positive womendhave had
less support and success. In addition, although PMTCT is often
the starting point for HIV-positive women to learn about their
HIV status and enrol in HIV care and treatment services, post-
partum follow-up of mothereinfant pairs is often problematic
for various reasons, including the lack of capacity of maternal
and child health services to provide HIV testing or follow-up to
HIV-exposed children.
13 14
Here we describe the estimated reduction in new child HIV
infections that has been achieved by providing PMTCT inter-
ventions in the 25 countries with the largest numbers of
HIV-positive pregnant women. We project the potential number
of child HIV infections that would be averted if 90% of
HIV-positive pregnant women were provided with ARVs
according to the new WHO guidelines, HIV incidence was
reduced by 50% in reproductive age women and unwanted
pregnancies were eliminated (by meeting all unmet family
planning needs). In addition, while the new PMTCT ARV
guidelines include prophylaxis during breastfeeding, we consider
the impact of prolonged breastfeeding by estimating the number
of new child infections that would be averted if the duration of
breastfeeding while receiving prophylaxis were limited to
12 months. Although breastfeeding in many settings is safer
than replacement feeding, it is important to recognise the
impact of breastfeeding on HIV transmission.
METHODS
Countries included in analysis
The 25 countries with the largest number of HIV-positive
pregnant women were chosen for this analysis based on their
2009 estimates reported in the 2010 Towards Universal Access
report.
15 These countries represent 91% of HIV-positive preg-
nant women in lower- and middle-income countries. The 25
countries are listed in table 1.
Model
In 2009 UNAIDS, WHO and partners conducted a series of
training sessions to assist country teams to develop models to
estimate and project their HIV epidemics using the Estimation
and Projection Package (EPP)
16 and Spectrum
17 software
package. Country teams reﬁned and improved the projections
and incorporated the latest available data. The country ﬁles used
for this analysis were submitted to UNAIDS by countries’ teams
in June 2010 and include data that were available at the end of
2009. Detailed descriptions of the methodologies for the models
are described elsewhere
16 17 while a brief description is provided
below.
Using HIV surveillance data from antenatal clinics and
nationally representative household surveys, EPP ﬁts epidemic
curves for various geographical subregions using a maximum-
likelihood approach. Incidence was estimated from prevalence
over time, while adjusting for the number of people receiving
antiretroviral therapy (ART).
16 Finally, the subnational curves
were aggregated to create national adult incidence curves.
HIV incidence among adults over time was transferred from
EPP into Spectrum. Using demographic data from the UN
Population Division’s World Population Prospects 2008 revision,
Spectrum projects men and women by age group over time
through different stages of HIV infection (or non-infection).
National programme data were entered into Spectrum and
parameters were modiﬁed based on available data. Data entered
intothemodelrelatedtocalculatingnewchildinfectionsincluded
the number of pregnant women receiving ARVs by regimen
(single, dual and triple prophylaxis or ART for their own health)
and type and duration of infant feeding by HIV-positive women.
When countries do not have data on infant feeding practices
among HIV-positive women, data from the general population
were used to proxy infant feeding among HIV-positive women.
Spectrum uses the HIVincidence data estimated from EPPand
creates age- and sex-speciﬁc HIV prevalence values. HIV preva-
lence was applied to the number of women in the age group
and then age-speciﬁc fertility rates, adjusted to account for the
lower fertility of HIV-positive women, were used to estimate
the number of births to HIV-positive women by age of the
mother.
18 19 See ﬁgure 1.
MTCTwas then calculated in two components: transmission
during pregnancy and delivery (perinatal transmission) and
transmission during breastfeeding. The assumed perinatal
transmission rates for different ARV regimens are shown in
table 2.
HIV-exposed infants born HIV-negative (uninfected) have
a monthly probability of HIV infection based on the infant
feeding method and duration as well as ARV use during breast-
feeding. The assumed monthly transmission rates during
breastfeeding are shown in table 3.
Scenarios
Spectrum was used to create ﬁve scenarios describing different
situations and different interventions. The ﬁve scenarios include:
1. No PMTCT. No ARVs were provided to prevent MTCTat any
point during the epidemic.
2. Base scenario. The 2009 programme was maintained through
2015dspeciﬁcally the number of women and the regimen
were kept constant from 2009 to 2015.
3. 90% on WHO guidelines. In 2010 the HIV-positive pregnant
women currently receiving ARVs were switched to the 2010
WHO-recommended interventions (providing ART for
women in need for their own health or starting women on
ARV prophylaxis at 14 weeks and continuing ARVs
throughout breastfeeding). The number of women receiving
ARVs or ARTwas increased linearly to reach 90% by 2015.
4. Prongs 1,2,3. In addition to the changes in scenario 3, new HIV
infections among reproductive age women were reduced by
50% and unmet need for family planning was eliminated.
HIVincidence and unmet need were reduced linearly between
2010 and 2015.
5. Prongs 1,2,3 and reduced breastfeeding.I na d d i t i o nt op r o n g s1 , 2 , 3 ,
median duration of breastfeeding among HIV-positive women
was reduced to 12 months. See table 1 for country values.
Four comparisons were made between the scenarios to
describe the impact of PMTCT.
Comparison 1
The no-PMTCT scenario described the situation if ARVs had
never been available to prevent MTCT in the 25 countries.
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SupplementComparing this scenario with existing coverage levels (the base
scenario) provided an estimate of the impact of providing
ARV prophylaxis, before the new WHO guidelines in the
25 countries.
The other comparisons were projections of what could be
achieved in the coming years given different intervention levels.
Comparison 2
The base scenario was compared with the scenario where 90% of
HIV-positive pregnant women received the 2010 WHO guide-
lines by 2015. All other elements of the epidemic remained the
same following the epidemic curve projected from existing
surveillance data.
Comparison 3
The base scenario was compared with the scenario in which
prongs 1, 2 and 3 are implemented by 2015.
Comparison 4
Again the base scenario was compared with a scenario where,
between 2010 and 2015, prongs 1, 2 and 3 are implemented and
the duration of breastfeeding was limited to 12 months.
Unmet need for family planning
To project unmet need for family planning (as in scenario 4), we
used the family planning module available in the Spectrum
computer package. This module allows the user to describe
changes in contraceptive prevalence during the timeline of the
projection. We linearly increased contraceptive prevalence from
the projected value in 2010 (values of contraceptive prevalence
are derived from household surveys and Spectrum then projects
them forward in time) to the projected value plus unmet need in
2015. A measure of unmet need was available for 24 of the 25
countries in this analysis. No data on unmet need for family
planning was available for Angola so the impact of increasing
family planning efforts in Angola was not included in this
analysis.
Unmet need for family planning is a common measure of
access to family planning and is deﬁned as the proportion of
sexually active, fecund women in a union who wish to stop or
postpone childbearing and are not currently using contraception.
The measure can be interpreted as the increase in contraceptive
prevalence rates if all women were able to fulﬁl their preferences.
This measure was collected in household surveys of the general
population. For PMTCT we were primarily interested in
reducing the unintended pregnancies among HIV-positive
women. The calculation of unmet need and its limitations have
been described elsewhere.
29 30
Table 1 presents the current levels of HIV incidence, unmet
need for family planning and ARV coverage as well as the target
values according to the scenarios described. Median duration of
breastfeeding among all women by country and the proportion
of pregnant women attending antenatal clinics is also provided
to indicate the magnitude of change required to reach the targets
set in the different scenarios.
The scenarios were implemented for each country individually
and results were aggregated to create one estimate for the 25
countries with the largest numbers of HIV-positive pregnant
women.
In this analysis we focused on new child infections as the
outcome, although we recognised that many other outcomes
could be quantiﬁed with other models and data. Future models
should ideally estimate HIV-free child survival as the overall goal
of interventions to prevent MTCTof HIV.
RESULTS
The scenarios described above were used to estimate the number
of new child infections (mother-to-child vertical HIVinfections),
including perinatal infections as well as postpartum infections
during breastfeeding.
Comparison 1
Between 2000 and 2009 an estimated 4.18 million children were
infected with HIV in the 25 countries. If no ART or ARV
prophylaxis had been provided to pregnant women approxi-
mately 4.45 million would have been infected. Cumulatively
269000 child HIV infections were prevented in the 25 countries
Table 2 Assumed perinatal HIV transmission rates for different
antiretroviral drug (ARV) regimens
ARV regimen Percentage Reference
No ARV 20 20
Single-dose nevirapine 11 21 22
Combination therapy using dual prophylaxis 4 23 24
Combination therapy using triple prophylaxis ARV 2 20
Highly active antiretroviral treatment 2
Table 3 Monthly HIV transmission rates during breastfeeding
Feeding method Percentage Reference
Replacement feeding 0
Mixed breastfeeding during months 1e6 1.5 25 26
Exclusive breastfeeding during months 1e6 0.75 25 27
Mixed breastfeeding 6e36 months 0.75 25 27
Breastfeeding in the presence of maternal ART
or effective ARV prophylaxis
0.3 28
ART, antiretroviral therapy; ARV, antiretroviral drug.
Figure 1 Summary of new child infections calculations. ARV, antiretroviral drug.
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Supplementby providing ARVs to HIV-positive pregnant women for
prophylaxis or treatment. An estimated 89000 child infections,
or a third of cumulative child infections, were averted in 2009
alone (there were an estimated 347000 new infections in the
25 countries in 2009). Comparing the estimated annual number
of new child infections in 2000 with the annual number of
new infections in 2009 shows a reduction of 24% among the
25 countries. See ﬁgure 2. (The slight decline in the no-PMTCT
scenario in later years reﬂects changes in the number of
HIV-positive pregnant women as incidence declined either
owing to natural progression of HIV or owing to prevention
efforts.)
Comparison 2
Projecting into the future, if current programmes were improved
so that by 2015 90% of HIV-positive pregnant women were
provided with ART or highly effective ARV prophylaxis during
pregnancy and throughout breastfeeding as currently recom-
mended by WHO, of the projected 2.1 million child infections
between 2010 and 2015 approximately 1041000 new child
infections would be averted (see ﬁgure 3). In the year 2015 alone,
229000 HIV infections would be averted among children. This is
a 60% reduction in the annual number of new child infections
between the year 2009 and 2015: a major step forward but still
well below the goal of a 90% reduction. Even after reaching 90%
of women with the new WHO recommended interventions
through pregnancy and breastfeeding there would still be
approximately 138000 new child infections in the year 2015 in
the 25 countries. The MTCT rate in 2015 would be approxi-
mately 11% if 90% of women were reached with PMTCT
services reﬂecting the WHO guidelines.
Comparison 3
If in addition to providing 90% of HIV-positive pregnant women
with ART or more effective ARVs as recommended by WHO,
new HIV infections among reproductive age women were
reduced by 50% and unmet need for family planning for HIV-
positive women was eliminated, the number of new HIV
infections among children could be further reduced. Imple-
menting these interventions simultaneously would avert
approximately 1174000 (of 2.1 million) new child HIV infec-
tions between 2010 and 2015, resulting in a 73% overall reduc-
tion in new child infections between the years 2009 and 2015
(see ﬁgure 3). As previously noted, including prongs 1 and 2
would not reduce the overall transmission rate, which would
remain at approximately 11%.
Comparison 4
The median duration of breastfeeding among women in these
countries was 22 months. If, in addition to the above interven-
tions, breastfeeding was limited to 12 months a total of
1306000 new child infections would be averted between 2010
and 2015; avoiding 264000 additional new child infections than
the scenario with the 2010 WHO recommendations alone (see
ﬁgure 3). This would result in a 79% reduction in annual new
child infections in the 25 countries between 2009 and 2015. An
estimated 72000 children would be infected with HIV through
vertical transmission in 2015 (see ﬁgure 4). Assuming that only
the women who receive ARVs (90%) are counselled about
reducing breastfeeding and the remaining 10% continue breast-
feeding patterns that are reﬂected in the general population, the
transmission rate would be approximately 8%.
LIMITATIONS
This analysis was limited by the fact that the transmission rates
in the model are based primarily on results from clinical studies
which might not reﬂect the effectiveness of national
programmes. These assumptions are being reviewed as new data
become available. The model currently does not differentiate
transmission rates by the CD4 level of the mother. Future
versions of the model will attempt to incorporate this difference.
In addition, data on the duration and methods of infant feeding
are not readily available for HIV-positive women, and especially
with the new recommendations of ARV prophylaxis during
breastfeeding. This limits our ability to estimate HIV trans-
mission during breastfeeding. Breastfeeding duration from the
general population was the most appropriate available data to
estimate duration of breastfeeding among HIV-positive women,
although this is likely to be an overestimate. However, analysis
from household surveys suggest little difference between the
breastfeeding practices of HIV-positive women (who reported
knowing their HIV status) and HIV-negative women.
31 Finally,
the models rely on programme data from the countries on
PMTCT coverage and ART coverage. These data can be of
varying quality
32 The data used for this analysis underwent
a global reconciliation process comparing data reported from
countries through multiple reporting mechanisms.
Figure 2 New HIV infections through
mother-to-child transmission (MTCT) if
antiretroviral drugs (ARVs) were not
available versus reported ARV coverage,
25 countries, 2000e9. PMTCT,
prevention of MTCT.
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Between 2000, when ARV prophylaxis for MTCTwas initiated
in developing countries, and 2009 approximately 269000 new
child infections were averted in the 25 highest burden countries
analysed here (representing approximately 91% of HIV-positive
pregnant women in low- and middle-income countries). There
was an estimated 24% reduction in the number of annual new
child infections between 2000 and 2009 as a result of PMTCT
ARV interventions. Targets are being set at global and country
level to reduce new infections due to MTCT by 90% over the
coming years. In 2009 there were an estimated 347000 new
child infections in the 25 countries. A 90% reduction in new
child infections would require fewer than 34700 new infections
in 2015 in the 25 countries.
Our study suggests there will still be 72000 new child infec-
tions in 2015 in the 25 highest burden countries if we rapidly
scale up PMTCT interventions (reaching 90% of women with
ART or highly effective ARV prophylaxis through delivery and
breastfeeding as currently recommended by WHO, halving new
HIV infections among reproductive age women, eliminating
Figure 3 New HIV infections through
mother-to-child transmission (MTCT) for
different scenarios, 25 countries,
2009e15. ARV, antiretroviral drug;
PMTCT, prevention of MTCT.
Figure 4 New HIV infections through mother-to-child transmission (MTCT), 25 countries, in the year 2015. ARV, antiretroviral drug; PMTCT,
prevention of MTCT.
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Supplementunmet need for contraception and reducing the duration of
breastfeeding to 12 months): a reduction of 79% in annual new
child infections between 2009 and 2015. Under these assump-
tions, the rate of MTCT would be 8%. Both projections repre-
sent signiﬁcant progress and reductions in new child infections,
but still fall short of the deﬁnition of virtual elimination: a 90%
reduction in new child infections or <5% transmission rate.
Reaching the ambitious new targets of virtual elimination
will require signiﬁcant resources and commitment, especially
in speciﬁc high-burden countries with major barriers. For
example Ethiopia, with very low antenatal care registration will
need to increase attendance at antenatal clinics from 28% to at
least 90%. Lesotho, with high HIV incidence in pregnant
women, will need to reduce incidence rates from 2.6% to 1.3%.
Uganda will need to increase the availability of family planning
so that contraceptive use will increase from 27% to 67% (see
table 1). On the other hand, 20 of the 25 countries have current
antenatal care coverage (at least one visit) >75% making it
feasible, with substantial effort, for these countries to reach
most women with PMTCT services. However, none of the 25
countries currently reach 90% of women with the recommended
four antenatal care visits (table 1), suggesting additional efforts
are needed.
This analysis shows the importance of moving rapidly to the
new, more effective ARV interventions recommended in the
2010 WHO guidelines, but also shows some of the limitations of
achieving virtual elimination, even with the new interventions.
Our analysis suggests that coverage with highly effective ARV
interventions will need to be >90% (probably >95%) and that
prolonged breastfeeding beyond 12 months, even with ARVs,
will increase the risk of new infections. To reach an approximate
80% reduction in new child infections, the duration of breast-
feeding with ARVs had to be limited to 12 months. Although
one recent clinical study found extremely low monthly trans-
mission rates among breastfeeding infants, the median monthly
transmission rate over 10 clinical trials with ARV interventions
between 2007 and 2010 was 0.3%.
28 33 Depending on the
duration of breastfeeding this transmission can accumulate to
signiﬁcantly increase the overall transmission rate. For example,
the probability of transmission during 12 months of breast-
feeding is 3.6%; adding the perinatal transmission rate with
100% of women on the 2010 WHO guideline interventions
results in an overall transmission rate of 5.6%.
Given our current understanding of infant feeding practices in
these 25 countries, reaching the virtual elimination goal of <5%
transmission rate may not be possible by providing ARVs alone.
Even if 100% of HIV-positive pregnant women were provided
with the 2010 WHO guideline interventions, a transmission rate
of <5% would only be possible if infant feeding were safer. In
Botswana, for example, the majority of HIV-positive women
choose to use replacement feed and vertical transmission is
estimated to be 3.7%.
34 However, replacement feeding is not
a simple intervention and can lead to higher infant mortality in
some settings.
35 More effort is needed to ensure that mothers are
fully informed about the risks and beneﬁts of breastfeeding
especially over long durations, as recommended in the WHO
Guidelines on HIV and Infant Feeding.
12 Even when women or
children are receiving ARVs to reduce transmission there is still
a probability of infection for each month that the child is
exposed to breast milk. As countries begin to scale up the new
WHO guidelines, including safer breastfeeding practices with
ARVs, new programme data are needed on the effectiveness of
ARV interventions during breastfeeding and the duration of
breastfeeding among HIV-positive women.
Caution is needed when interpreting the additional impact of
the different interventions. The impact of the interventions
depends on the order in which they are implemented. For
example, if unmet need for family planning was eliminated
before ARVs were provided we would estimate that family
planning had a much larger impact on reducing new child
infections. We could also hypothesise that by eliminating unmet
need for family planning, women living with HIV would have
the children they want when they want them. This also means
that the pregnancies at which PMTCT ARVs are directed would
be largely wanted pregnancies. Women with such pregnancies
might have a higher motivation to adhere to PMTCTregimens,
a crucial factor given the earlier start and longer duration of
ARVs recommended by the 2010 WHO guidelines. In practice,
the interventions would not be implemented individually thus
we have not estimated the individual impact of interventions
here.
The PMTCT interventions described here can dramatically
reduce new child HIV infections. However, these interventions
have many additional beneﬁts beyond reducing new child HIV
infections. By eliminating unmet need for family planning and
reducing HIV incidence by 50% in the top 25 countries 50%
fewer pregnant women would be HIV positive, approximately
36 million (cumulative between 2010 and 2015) unwanted
births would be avoided among all women, and 1209000 fewer
HIV-positive pregnant women would require ARV prophylaxis.
Much of the global effort for PMTCT has been focused on
prong 3, provision of ARV prophylaxis. Additional efforts are
needed on prong 1, primary prevention, and prong 2, meeting
the unmet need for family planning among women living with
HIV to reduce child infections. Meeting the current unmet need
for family planning at a country level will require considerable
effort. Yet countries are more likely to reach virtual elimination
if they raise demand for family planning, and strengthen
programmes to meet this demand. The measure of unmet need
used in this analysis is based on all women and is thus likely to
be an underestimate of unmet need for HIV-positive women.
36
Thus the impact of meeting unmet need for family planning
might be larger than predicted in this analysis. If more women
are reached with testing and counselling the demand for family
planning might be even greater.
Meeting global and country-speciﬁc targets for virtual elimi-
nation of MTCTof HIV will take an enormous amount of effort
and resources from government, civil society and donors. The
ﬁnancial requirements should be carefully considered to help
countries plan effective, efﬁcient interventions to reach these
goals. Clear progress has been made in the ﬁrst 10 years of this
global effort. With the scale-up of more effective ARV
Key messages
< Progress has been made in the ﬁrst 10 years of prevention of
mother-to-child transmission but signiﬁcant resources are
required to reach virtual elimination by 2015.
< Even after providing the WHO recommended antiretroviral
drug prophylaxis or antiretroviral treatment to 90% of HIV-
positive pregnant women, prolonged breastfeeding will results
in continued new child infections.
< Strengthening programmes to improve access to family
planning and reduce new HIV infections will be critical to
reach the virtual elimination targets.
ii54 Sex Transm Infect 2010;86(Suppl 2):ii48eii55. doi:10.1136/sti.2010.045989
Supplementinterventions, together with a comprehensive approach to
reduce new infections in pregnant women and meet family
planning needs, rapid progress can be made towards virtual
elimination.
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